Nomura Holdings Inc Nektar Therapeutics Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $96,707 - $188,228	-30,507 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$4.16 - $13.72 $126,909 - $418,556	30,507 New	30,507 $170,000
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $1.47 Million - $3.31 Million	-31,711 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$57.4 - $108.44 $1.82 Million - $3.44 Million	31,711 New	31,711 $3.37 Million

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.